AC Immune to receive milestone payment for Anti-Tau Antibody moving into Phase 1 trial for Alzheimer's disease
07.July 2016 08:00 CET
English
Français
Deutsch
AC Immune to receive second milestone payment of CHF14 million under collaboration agreement with Genentech
